ANIX
Anixa BiosciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ANIX Profile
Anixa Biosciences, Inc.
A biotechnology company focused on the treatment and prevention of cancer and infectious diseases
3150 Almaden Expressway, Suite 250, San Jose, CA 95118
--
Anixa Biosciences, Inc., incorporated under the laws of the State of Delaware on November 5, 1982, is a biotechnology company dedicated to the development of therapies and vaccines for critical unmet needs in oncology and infectious diseases. The company's main business is the development of chimeric endocrine receptor T cell technology and the discovery and eventual development of anticancer drugs - viral drug candidates for the treatment of COVID - 19 focus on inhibiting certain viral protein functions of the virus.
